CN112300186B - Process for preparing hexahydrofurofuranol derivative, intermediate and process for preparing the same - Google Patents
Process for preparing hexahydrofurofuranol derivative, intermediate and process for preparing the same Download PDFInfo
- Publication number
- CN112300186B CN112300186B CN201910706770.0A CN201910706770A CN112300186B CN 112300186 B CN112300186 B CN 112300186B CN 201910706770 A CN201910706770 A CN 201910706770A CN 112300186 B CN112300186 B CN 112300186B
- Authority
- CN
- China
- Prior art keywords
- compound
- acid
- ethyl acetate
- reaction
- concentrating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- GQSAIMYKDAPIDJ-UHFFFAOYSA-N 2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-ol Chemical class O1CCC2OC(O)CC21 GQSAIMYKDAPIDJ-UHFFFAOYSA-N 0.000 title abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 69
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 64
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 51
- 238000006243 chemical reaction Methods 0.000 claims description 49
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 46
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 36
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 32
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 23
- 239000000706 filtrate Substances 0.000 claims description 20
- 238000005070 sampling Methods 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 17
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 238000001514 detection method Methods 0.000 claims description 13
- 239000012065 filter cake Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 7
- 238000002386 leaching Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- RCDXYCHYMULCDZ-HCWXCVPCSA-N (3as,4r,6ar)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-ol Chemical compound O1CC[C@H]2[C@@H](O)CO[C@H]21 RCDXYCHYMULCDZ-HCWXCVPCSA-N 0.000 claims 2
- RCDXYCHYMULCDZ-UHFFFAOYSA-N 2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-ol Chemical compound O1CCC2C(O)COC21 RCDXYCHYMULCDZ-UHFFFAOYSA-N 0.000 claims 2
- 206010013781 dry mouth Diseases 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 19
- 238000007363 ring formation reaction Methods 0.000 abstract description 18
- 125000000217 alkyl group Chemical group 0.000 abstract description 14
- 239000000543 intermediate Substances 0.000 abstract description 14
- 238000010511 deprotection reaction Methods 0.000 abstract description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 10
- CJBJHOAVZSMMDJ-HEXNFIEUSA-N darunavir Chemical compound C([C@@H]([C@H](O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)NC(=O)O[C@@H]1[C@@H]2CCO[C@@H]2OC1)C1=CC=CC=C1 CJBJHOAVZSMMDJ-HEXNFIEUSA-N 0.000 abstract description 8
- 229960005107 darunavir Drugs 0.000 abstract description 8
- 125000003118 aryl group Chemical group 0.000 abstract description 7
- 238000006482 condensation reaction Methods 0.000 abstract description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 6
- 125000002252 acyl group Chemical group 0.000 abstract description 5
- 150000002148 esters Chemical class 0.000 abstract description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 3
- 239000001257 hydrogen Substances 0.000 abstract description 3
- 229910052757 nitrogen Chemical group 0.000 abstract description 3
- 229910052760 oxygen Inorganic materials 0.000 abstract description 3
- 239000001301 oxygen Substances 0.000 abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 abstract description 3
- 239000011593 sulfur Chemical group 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 24
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 16
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 16
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 16
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 16
- SIEILFNCEFEENQ-UHFFFAOYSA-N dibromoacetic acid Chemical compound OC(=O)C(Br)Br SIEILFNCEFEENQ-UHFFFAOYSA-N 0.000 description 16
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 16
- -1 methoxy alcohol Chemical compound 0.000 description 13
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 150000007522 mineralic acids Chemical class 0.000 description 12
- 150000007524 organic acids Chemical class 0.000 description 12
- 239000002841 Lewis acid Substances 0.000 description 10
- 239000003513 alkali Substances 0.000 description 10
- 150000007517 lewis acids Chemical class 0.000 description 10
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 229910015900 BF3 Inorganic materials 0.000 description 8
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 229960005215 dichloroacetic acid Drugs 0.000 description 8
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 8
- YHBDIEWMOMLKOO-UHFFFAOYSA-I pentachloroniobium Chemical compound Cl[Nb](Cl)(Cl)(Cl)Cl YHBDIEWMOMLKOO-UHFFFAOYSA-I 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- AFPHTEQTJZKQAQ-UHFFFAOYSA-N 3-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1 AFPHTEQTJZKQAQ-UHFFFAOYSA-N 0.000 description 6
- ONMOULMPIIOVTQ-UHFFFAOYSA-N 98-47-5 Chemical compound OS(=O)(=O)C1=CC=CC([N+]([O-])=O)=C1 ONMOULMPIIOVTQ-UHFFFAOYSA-N 0.000 description 6
- 229940125810 compound 20 Drugs 0.000 description 6
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 6
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 6
- 125000003710 aryl alkyl group Chemical group 0.000 description 5
- 230000032798 delamination Effects 0.000 description 5
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 description 4
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 4
- 229910052736 halogen Chemical group 0.000 description 4
- 150000002367 halogens Chemical group 0.000 description 4
- 150000007529 inorganic bases Chemical class 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- 229910052759 nickel Inorganic materials 0.000 description 4
- 150000007530 organic bases Chemical class 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229940125773 compound 10 Drugs 0.000 description 3
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 3
- 229940124321 AIDS medicine Drugs 0.000 description 2
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 125000003435 aroyl group Chemical group 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 125000001033 ether group Chemical group 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 125000004971 nitroalkyl group Chemical group 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical group C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- HIAZFYQNGXRLTF-UHFFFAOYSA-N tributylsilane Chemical group CCCC[SiH](CCCC)CCCC HIAZFYQNGXRLTF-UHFFFAOYSA-N 0.000 description 2
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical group CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 2
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical group C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical class OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 150000003608 titanium Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
The invention relates to the field of medicine synthesis, in particular to a preparation method of hexahydrofurofuranol derivatives, intermediates thereof and a preparation method thereof. The preparation method comprises condensation reaction, deprotection and cyclization reaction,Wherein R 1 and R 2 are hydrogen or hydroxyl protecting groups, R 3 is alkyl, acyl, ether, ester or aryl, and X is oxygen, sulfur or nitrogen. In the preparation process of hexahydrofurofuranol derivatives, the compound of the formula I can prepare a product with very high optical purity by adopting the way through condensation reaction. The preparation method can realize commercial production of the key intermediate (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-alcohol of darunavir, and is a very economical route suitable for industrial production.
Description
Technical Field
The invention relates to the field of medicine synthesis, in particular to a preparation method of hexahydrofurofuranol derivatives, intermediates thereof and a preparation method thereof.
Background
The compound having the structure of formula IV below is the chemical name (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-ol:
Belonging to one of hexahydrofurofuranol derivatives, and being an intermediate of darunavir as an anti-AIDS drug.
The racemization structure of the darunavir belongs to an intermediate of the darunavir which is an anti-AIDS drug.
Chinese patent application CN101541775 discloses the reaction of glyoxylate derivatives of formula (III) wherein n is 0, 1, 2 or 3 and R is alkyl or arylalkyl, using 2, 3-dihydrofuran of formula (II) in the presence of a titanium salt of formula Ti (Hal) n(OR)4-n, and subsequently reacting the resulting reaction product with an alcohol of formula (IV) to form a compound of formula (V):
Wherein R 1 is alkyl or arylalkyl and R 2 is alkyl or arylalkyl;
reducing the resulting compound of formula (V) to form a compound of formula (VI);
cyclizing the compound of formula (VI) to form a compound of formula (I);
Chiral separation is carried out to obtain (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-alcohol.
The invention prepares (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-alcohol and the report of the preparation method of hexahydrofuro [2,3-b ] -3-alcohol by condensation, deprotection and cyclization reaction is basically in a blank state, and the method has simple operation, relatively high yield and strong applicability of industrialized amplification production. The method brings great help to both the economic benefit and the operation flow of the drug synthesis.
Disclosure of Invention
The process for the preparation of (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-ol and-hexahydrofuro [2,3-b ] -3-ol of the present invention starts with reaction with methoxy alcohol and has been studied to develop a process for the preparation of key intermediates of darunavir which is different from the starting materials in the existing patent applications. The preparation method provided by the invention has the advantages of low cost and mild reaction conditions, and provides another route suitable for industrialization for the preparation of the darunavir key intermediate.
In order to achieve the technical purpose of the invention, the invention provides the following technical scheme:
In a first aspect the present invention provides an intermediate compound for the preparation of (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-ol having the structural formula:
Wherein, R 1 and R 2 are hydrogen or hydroxyl protecting groups, and R 3 is alkyl, acyl, ether, ester or aryl; x is oxygen, sulfur or nitrogen. The hydroxyl protecting group is alkyl, silyl, acyl of C 2-11, cycloalkenyl of C 4-9, aryl, aralkyl, aroyl, phenyl, substituted phenyl, ether of C 2-11, ester of C 2-11; the silane group is tetramethylsilane group, trimethylsilane group, triethylsilane group, tri-n-butylsilane group and tert-butyldimethylsilyl group; the alkyl is C 1-C8 alkyl; the aryl is phenyl, furyl, thienyl or indolyl; the substituted phenyl is alkyl substituted phenyl, alkoxyalkyl substituted phenyl, nitroalkyl substituted phenyl or halogen substituted phenyl; the phenyl substituted by the alkyl is benzyl, benzhydryl and trityl; the phenyl substituted by the alkoxyalkyl is p-methoxybenzyl; the nitroalkyl-substituted phenyl is p-nitrobenzyl; the halogen substituted phenyl is p-chlorophenyl, and the ether group is oxyether or thioether; the ester group is carbonyl ester, sulfate or phosphate.
In a second aspect, the invention provides a process for the preparation of (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-ol of formula IV by cyclization of a compound of formula II' in the presence of an acid,
Wherein R 2、R3 and X are as defined above;
The acid in the cyclization reaction step is organic acid, inorganic acid or Lewis acid.
The organic acid is selected from p-toluenesulfonic acid, dichloroacetic acid, dibromoacetic acid and m-nitrobenzenesulfonic acid, the m-nitrobenzoic acid, the inorganic acid is selected from nitrous acid, hydrofluoric acid, hydrochloric acid, sulfuric acid and phosphoric acid, and the Lewis acid is selected from aluminum chloride, ferric chloride, boron trifluoride and niobium pentachloride, and is preferably hydrochloric acid;
The reaction temperature of the cyclization reaction step is-10-20 ℃, preferably-5-15 ℃.
The third aspect of the invention provides a preparation method of (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-alcohol formula IV, which is prepared by deprotection of the compound of the formula II under the existence of acid, alkali or metal catalyst to obtain the compound of the formula II ', and then cyclizing the compound of the formula II' under the existence of acid,
Wherein R 1,R2、R3 and X are as defined above;
The alkali in the deprotection step is organic alkali or inorganic alkali;
the organic base is selected from triethylamine, trimethylamine, diisopropylethylamine, diazabicyclo, pyridine and imidazole, the inorganic base is selected from potassium carbonate, sodium carbonate, cesium carbonate, potassium hydroxide, sodium hydroxide, lithium hydroxide, sodium borohydride, lithium aluminum hydride and red aluminum, the metal catalyst is selected from palladium reagent and nickel reagent, and preferably sodium carbonate;
The reaction temperature of the deprotection step is 10-50 ℃, preferably 15-35 ℃;
The acid in the cyclization reaction step is organic acid, inorganic acid or Lewis acid;
The organic acid is selected from p-toluenesulfonic acid, dichloroacetic acid, dibromoacetic acid, m-nitrobenzenesulfonic acid and m-nitrobenzoic acid, the inorganic acid is selected from nitrous acid, hydrofluoric acid, hydrochloric acid, sulfuric acid and phosphoric acid, and the Lewis acid is selected from aluminum chloride, ferric chloride, boron trifluoride and niobium pentachloride, and is preferably hydrochloric acid;
The reaction temperature of the cyclization reaction step is-10-20 ℃, preferably-5-15 ℃.
The fourth aspect of the invention provides a preparation method of (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-alcohol formula IV, which is prepared by condensation reaction of a compound of formula I in the presence of acid to obtain a compound of formula II, deprotection of the compound of formula II in the presence of acid or alkali to obtain a compound of formula II ', cyclization of the compound of formula II in the presence of acid to obtain the compound of formula II',
Wherein, R 1,R2、R3 and X are defined as above.
The organic acid is selected from p-toluenesulfonic acid, dichloroacetic acid, dibromoacetic acid, m-nitrobenzenesulfonic acid and m-nitrobenzoic acid, and the inorganic acid is selected from nitrous acid, hydrofluoric acid, hydrochloric acid, sulfuric acid, phosphoric acid, aluminum chloride, ferric chloride, boron trifluoride and niobium pentachloride, preferably p-toluenesulfonic acid;
The reaction temperature of the condensation reaction step is 10-50 ℃, preferably 15-35 ℃;
the organic base is selected from triethylamine, trimethylamine, diisopropylethylamine, diazabicyclo, pyridine and imidazole, the inorganic base is selected from potassium carbonate, sodium carbonate, cesium carbonate, potassium hydroxide, sodium hydroxide, lithium hydroxide, sodium borohydride, lithium aluminum hydride and red aluminum, the metal catalyst is selected from palladium reagent and nickel reagent, and preferably sodium carbonate;
The reaction temperature of the deprotection step is 10-50 ℃, preferably 15-35 ℃;
The organic acid is selected from p-toluenesulfonic acid, dichloroacetic acid, dibromoacetic acid and m-nitrobenzene, the inorganic acid is selected from nitrous acid, hydrofluoric acid, hydrochloric acid, sulfuric acid and phosphoric acid, and the Lewis acid is selected from aluminum chloride, ferric chloride, boron trifluoride and niobium pentachloride, preferably hydrochloric acid;
The reaction temperature of the cyclization reaction step is-10-20 ℃, preferably-5-15 ℃.
The reaction temperature of the cyclization reaction step is-10-20 ℃, preferably-5-15 ℃.
The preparation method of the (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-alcohol has the advantages of low cost and mild reaction conditions, and provides another route suitable for industrialization for the preparation of the darunavir key intermediate.
In a fifth aspect the present invention provides hexahydrofuro [2,3-b ] -3-ol intermediate compounds of formula V having the formula:
Or an isomer thereof.
Wherein, R 1 and R 2 are hydrogen or hydroxyl protecting groups, and R 3 is alkyl, acyl, ether, ester or aryl; x is oxygen, sulfur or nitrogen. The hydroxyl protecting group is alkyl, silyl, acyl of C 2-11, cycloalkenyl of C 4-9, aryl, aralkyl, aroyl, phenyl, substituted phenyl, ether of C 2-11, ester of C 2-11; the silane group is tetramethylsilane group, trimethylsilane group, triethylsilane group, tri-n-butylsilane group and tert-butyldimethylsilyl group; the alkyl is C 1-C8 alkyl; the aryl is phenyl, furyl, thienyl or indolyl; the substituted phenyl is alkyl substituted phenyl, alkoxyalkyl substituted phenyl, nitroalkyl substituted phenyl or halogen substituted phenyl; the phenyl substituted by the alkyl is benzyl, benzhydryl and trityl; the phenyl substituted by the alkoxyalkyl is p-methoxybenzyl; the nitroalkyl-substituted phenyl is p-nitrobenzyl; the halogen substituted phenyl is p-chlorophenyl, and the ether group is oxyether or thioether; the ester group is carbonyl ester, sulfate or phosphate.
The sixth aspect of the invention provides a process for preparing hexahydrofuro [2,3-b ] -3-ol of formula VI, which comprises cyclizing an intermediate compound of formula V' in the presence of an acid,
Wherein R 2、R3 and X are as defined above;
The acid in the cyclization reaction step is organic acid, inorganic acid or Lewis acid.
The organic acid is selected from p-toluenesulfonic acid, dichloroacetic acid, dibromoacetic acid and m-nitrobenzenesulfonic acid, the m-nitrobenzoic acid, the inorganic acid is selected from nitrous acid, hydrofluoric acid, hydrochloric acid, sulfuric acid and phosphoric acid, and the Lewis acid is selected from aluminum chloride, ferric chloride, boron trifluoride and niobium pentachloride, and is preferably hydrochloric acid;
The reaction temperature of the cyclization reaction step is-10-20 ℃, preferably-5-15 ℃.
The seventh aspect of the invention provides a method for preparing hexahydrofuro [2,3-b ] -3-alcohol formula VI, which comprises the steps of preparing a compound of formula V 'from an intermediate formula V through deprotection under the condition of acid, alkali or metal catalyst, and then preparing the compound of formula V' through cyclization reaction in the presence of acid,
Wherein R 1,R2、R3 and X are as defined above;
The alkali in the deprotection step is organic alkali or inorganic alkali;
the organic base is selected from triethylamine, trimethylamine, diisopropylethylamine, diazabicyclo, pyridine and imidazole, the inorganic base is selected from potassium carbonate, sodium carbonate, cesium carbonate, potassium hydroxide, sodium hydroxide, lithium hydroxide, sodium borohydride, lithium aluminum hydride and red aluminum, the metal catalyst is selected from palladium reagent and nickel reagent, and preferably sodium carbonate;
The reaction temperature of the deprotection step is 10-50 ℃, preferably 15-35 ℃;
The acid in the cyclization reaction step is organic acid, inorganic acid or Lewis acid;
The organic acid is selected from p-toluenesulfonic acid, dichloroacetic acid, dibromoacetic acid, m-nitrobenzenesulfonic acid and m-nitrobenzoic acid, the inorganic acid is selected from nitrous acid, hydrofluoric acid, hydrochloric acid, sulfuric acid and phosphoric acid, and the Lewis acid is selected from aluminum chloride, ferric chloride, boron trifluoride and niobium pentachloride, and is preferably hydrochloric acid;
The reaction temperature of the cyclization reaction step is-10-20 ℃, preferably-5-15 ℃.
The eighth aspect of the invention provides a method for preparing hexahydrofuro [2,3-b ] -3-alcohol formula VI, which comprises the steps of preparing a compound of formula V by condensation reaction of a compound of formula I in the presence of acid, preparing a compound of formula V 'by deprotection of the compound of formula V in the presence of acid, alkali or metal catalyst, preparing the compound of formula V' by cyclization reaction of the compound of formula V in the presence of acid,
Wherein, R 1,R2、R3 and X are defined as above.
The organic acid is selected from p-toluenesulfonic acid, dichloroacetic acid, dibromoacetic acid, m-nitrobenzenesulfonic acid and m-nitrobenzoic acid, and the inorganic acid is selected from nitrous acid, hydrofluoric acid, hydrochloric acid, sulfuric acid, phosphoric acid, aluminum chloride, ferric chloride, boron trifluoride and niobium pentachloride, preferably p-toluenesulfonic acid;
The reaction temperature of the condensation reaction step is 10-50 ℃, preferably 15-35 ℃;
the organic base is selected from triethylamine, trimethylamine, diisopropylethylamine, diazabicyclo, pyridine and imidazole, the inorganic base is selected from potassium carbonate, sodium carbonate, cesium carbonate, potassium hydroxide, sodium hydroxide, lithium hydroxide, sodium borohydride, lithium aluminum hydride and red aluminum, the metal catalyst is selected from palladium reagent and nickel reagent, and preferably sodium carbonate;
The reaction temperature of the deprotection step is 10-50 ℃, preferably 15-35 ℃;
The organic acid is selected from p-toluenesulfonic acid, dichloroacetic acid, dibromoacetic acid and m-nitrobenzene, the inorganic acid is selected from nitrous acid, hydrofluoric acid, hydrochloric acid, sulfuric acid and phosphoric acid, and the Lewis acid is selected from aluminum chloride, ferric chloride, boron trifluoride and niobium pentachloride, preferably hydrochloric acid;
The reaction temperature of the cyclization reaction step is-10-20 ℃, preferably-5-15 ℃.
The reaction temperature of the cyclization reaction step is-10-20 ℃, preferably-5-15 ℃.
The method for preparing hexahydrofuro [2,3-b ] -3-alcohol has low cost and mild reaction conditions, and provides another route suitable for industrialization for preparing the darunavir key intermediate
Detailed Description
For a further understanding of the present invention, the preparation of (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -3-ol and-hexahydrofuro [2,3-b ] -3-ol by the process provided in the present invention is described in detail below in connection with examples. It should be understood that these examples are presented merely to further illustrate the features of the present invention and are not intended to limit the scope of the invention or the scope of the claims.
Example 1:
to a dry four-necked flask, compound I (1.0 g,3.96 mmol), ethylene glycol methyl ether 4g and p-toluenesulfonic acid monohydrate (0.038 g,0.22 mmol) were added, and after the reaction was carried out at 20 to 25℃with stirring for about 1 hour, sampling and detection were carried out, and after the reaction was completed, sodium carbonate was neutralized, and concentrated to dryness at 60 to 70℃under reduced pressure to give oily Compound II.
To the compound II, 4g of methanol and sodium carbonate (0.21 g,1.98 mmol) were added, and the mixture was reacted at 20 to 25℃for 5 to 8 hours with sampling. After the reaction is finished, filtering, leaching a filter cake by using a proper amount of methanol, decompressing and concentrating filtrate at 40-50 ℃ until the filtrate is dried, and obtaining a sticky substance. 3ml of water and 1ml of toluene were added and stirred, and the mixture was allowed to stand for delamination, and an aqueous layer was collected, which was an aqueous solution of Compound III.
The temperature of the aqueous solution of the compound III is reduced by 0 to 5 ℃, concentrated hydrochloric acid (0.45 g,4.38 mmol) is added, the temperature is kept for about 8 hours at 0 to 5 ℃, and sampling GC detection is carried out. After the reaction, the pH value is adjusted to be slightly alkaline with sodium carbonate=7-8, and the mixture is concentrated to be dry under reduced pressure at 60-70 ℃ to obtain a sticky substance. Ethyl acetate was added to stir, filter, the filter cake was rinsed with ethyl acetate, and the filtrate was collected. Concentrating under reduced pressure until no liquid flows out, 0.54g of oily compound IV is obtained, the yield is 89.4%, and the GC purity is 86.3%.
Example 2:
to a dry four-necked flask, compound I '(1.3 g,5.15 mmol), ethylene glycol methyl ether 5g and p-toluenesulfonic acid monohydrate (0.049 g,0.26 mmol) were added, the mixture was stirred at 25 to 30℃under constant temperature, the reaction was carried out for 1 hour, sampling and detection were carried out, sodium carbonate was neutralized after the completion of the reaction, and the mixture was concentrated to dryness under reduced pressure at 60 to 70℃to obtain oily Compound II'.
To the compound II', 5g of methanol and sodium carbonate (0.27 g,2.55 mmol) were added, and the mixture was reacted at 22 to 28℃with a constant temperature for 10 hours, followed by sampling and detection. The raw materials disappear, the reaction is stopped, the filter cake is leached by methanol, and the filtrate is decompressed and concentrated to dryness at 45-50 ℃ to obtain viscous oily matter. 3ml of water and 1ml of toluene were added and stirred, and the mixture was allowed to stand for delamination, and an aqueous layer was collected, which was an aqueous solution of compound III'.
The temperature of the aqueous solution of the compound III' is reduced to-2 to 3 ℃, concentrated hydrochloric acid (0.58 g,5.66 mmol) is added, and the temperature is kept at-2 to 3 ℃ for about 6 to 9 hours, and sampling GC detection is carried out. After the reaction, the pH value is adjusted to be slightly alkaline by sodium carbonate=7-8, and the mixture is concentrated to be dry at 55-70 ℃ under reduced pressure to obtain a sticky substance. Ethyl acetate was added to stir, filter, the filter cake was rinsed with ethyl acetate, and the filtrate was collected. Concentrating under reduced pressure until no liquid flows out, 0.68g of oily compound IV' is obtained, the yield is 85.6%, and the GC purity is 88.1%.
Example 3:
To a dry four-necked flask, compound 10 (1.8 g,7.13 mmol), ethylene glycol methyl ether 7.2g and p-toluenesulfonic acid monohydrate (0.068 g,0.36 mmol) were added, the mixture was stirred at 22 to 26℃under constant temperature, the reaction was carried out for about 0.5 to 1 hour, sampling and detection were carried out, sodium carbonate was neutralized after completion of the reaction, and the mixture was concentrated to dryness under reduced pressure at 60 to 70℃to give oily compound 20.
7G of methanol and sodium carbonate (0.38 g,3.56 mmol) are added into the compound 20, the temperature is kept between 22 and 26 ℃ for reaction, and sampling and detection are carried out for 6 to 10 hours. After the reaction is finished, filtering, leaching with a proper amount of methanol, decompressing and concentrating the filtrate at 40-50 ℃ until the filtrate is dried, and obtaining a sticky substance. 5ml of toluene and 2ml of toluene were added thereto, and the mixture was stirred, allowed to stand for delamination, and an aqueous layer was collected, which was an aqueous solution of Compound 30.
The temperature of the aqueous solution of the compound 30 is reduced to-2 to 5 ℃, concentrated hydrochloric acid (0.85 g,8.5 mmol) is added, the temperature is kept at 0 to 5 ℃ for 5 to 8 hours, and sampling GC detection is carried out. After the reaction, the pH=7-8 was adjusted with sodium carbonate, and concentrated to dryness under reduced pressure at 50-70℃to give an oil. Ethyl acetate was added to stir, filter, the filter cake was rinsed with ethyl acetate, and the filtrate was collected. Concentrating under reduced pressure until no liquid flows out, 0.95g of oily compound 40 is obtained, the yield is 90.4%, and the GC purity is 87.5%.
Example 4:
To a dry four-necked flask, compound 10 '(1.5 g,5.95 mmol), ethylene glycol methyl ether 6g and p-toluenesulfonic acid monohydrate (0.057 g,0.3 mmol) were added, and after the reaction was carried out at 20 to 25℃with stirring and with stirring for about 1 hour, sampling and detection were carried out, and after the reaction was completed, sodium carbonate was neutralized, and then concentrated to dryness under reduced pressure at 60 to 70℃was started to obtain an oily compound 20'.
6G of methanol and sodium carbonate (0.32 g,2.98 mmol) were added to the compound 20', and the mixture was reacted at 25 to 30℃for 8 to 10 hours with sampling. After the reaction is finished, filtering, eluting with methanol, decompressing and concentrating filtrate at 40-50 ℃ until the filtrate is dried to obtain oily matter. 5ml of toluene and 2ml of toluene were added thereto, and the mixture was stirred, allowed to stand for delamination, and an aqueous layer was collected, which was an aqueous solution of Compound 30'.
The temperature of the 30' aqueous solution of the compound is reduced to-1 to 5 ℃, concentrated hydrochloric acid (0.67 g,6.54 mmol) is added, and the temperature is kept for about 8 to 10 hours at 0 to 5 ℃. After the reaction, the pH=7-8 is adjusted by sodium carbonate, and the mixture is concentrated to dryness under reduced pressure at 50-70 ℃ to obtain a sticky substance. Ethyl acetate was added to stir, filter, the filter cake was rinsed with ethyl acetate, and the filtrate was collected. Concentrating under reduced pressure until no liquid flows out, 0.8g of oily compound 40' is obtained, the yield is 85.0%, and the GC purity is 80.2%.
Example 5:
To a dry four-necked flask, compound 10 '(1.5 g,5.95 mmol), ethylene glycol methyl ether 6g and p-toluenesulfonic acid monohydrate (0.057 g,0.3 mmol) were added, and after the reaction was carried out at 20 to 25℃with stirring and with stirring for about 1 hour, sampling and detection were carried out, and after the reaction was completed, sodium carbonate was neutralized, and then concentrated to dryness under reduced pressure at 60 to 70℃was started to obtain an oily compound 20'.
6G of methanol and sodium carbonate (0.32 g,2.98 mmol) were added to the compound 20', and the mixture was reacted at 25 to 30℃for 8 to 10 hours with sampling. After the reaction is finished, filtering, eluting with methanol, decompressing and concentrating filtrate at 40-50 ℃ until the filtrate is dried to obtain oily matter. 5ml of toluene and 2ml of toluene were added thereto, and the mixture was stirred, allowed to stand for delamination, and an aqueous layer was collected, which was an aqueous solution of Compound 30'.
The temperature of the 30' aqueous solution of the compound is reduced to-1 to 5 ℃, concentrated hydrochloric acid (0.67 g,6.54 mmol) is added, and the temperature is kept for about 8 to 10 hours at 0to 5 ℃. After the reaction, the pH=7-8 is adjusted by sodium carbonate, and the mixture is concentrated to dryness under reduced pressure at 50-70 ℃ to obtain a sticky substance. Ethyl acetate was added to stir, filter, the filter cake was rinsed with ethyl acetate, and the filtrate was collected. Concentrating under reduced pressure until no liquid flows out, 0.8g of oily compound 40' is obtained, the yield is 84.0%, and the GC purity is 80%.
Claims (4)
1. A process for preparing (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -furan-3-ol IV is characterized in that methanol and sodium carbonate are added into a compound II, the reaction is carried out at 20-25 ℃ for 5-8 h, sampling and detection are carried out, after the reaction is finished, filtering, leaching filter cake with a proper amount of methanol, decompressing and concentrating the filtrate at 40-50 ℃ until dryness to obtain a sticky substance, adding water and toluene, stirring, standing for layering, collecting a water layer, the water layer is a compound II 'aqueous solution, cooling the compound II' aqueous solution by 0-5 ℃, adding concentrated hydrochloric acid, preserving heat for about 8h at 0-5 ℃, sampling GC detection, adjusting pH value to 7-8 with sodium carbonate after the reaction is finished, decompressing and concentrating to dryness at 60-70 ℃ to obtain the sticky substance, adding ethyl acetate, stirring, filtering, leaching filter cake with ethyl acetate, collecting filtrate, decompressing and concentrating until no liquid flows out,
The compound II is:
the compound II' is:
2. A process for preparing (3R, 3aS,6 aR) -hexahydrofuro [2,3-b ] -furan-3-ol IV is characterized in that a dry four-mouth flask is added with a compound I, ethylene glycol methyl ether and p-toluenesulfonic acid, the mixture is stirred at a temperature of 20-25 ℃, after the reaction is carried out for about 1 hour, sampling detection is carried out, sodium carbonate is neutral after the reaction is finished, the mixture is concentrated to dryness at 60-70 ℃ under reduced pressure to obtain an oily compound II, methanol and sodium carbonate are added into the compound II, the mixture is subjected to heat preservation reaction at 20-25 ℃ for 5-8 hours, after the reaction is finished, a filter cake is leached by a proper amount of methanol, the filtrate is subjected to reduced pressure and concentrated to dryness at 40-50 ℃ to obtain a sticky substance, water and toluene are added and stirred, the mixture is kept for layering, a water layer is collected, the water layer is an aqueous solution of the compound II', the aqueous solution is cooled to 0-5 ℃, concentrated hydrochloric acid is added at 0-5 ℃ and the temperature of about 8 hours, the sample is carried out after the reaction is finished, sodium carbonate is subjected to reduced pressure concentration to pH=7-8, the mixture is subjected to reduced pressure and alkaline pH=60-70 ℃, the mixture is leached to obtain a sticky filter cake, ethyl acetate is concentrated, ethyl acetate is obtained, the sticky filter cake is obtained, ethyl acetate is concentrated, ethyl acetate is obtained, and ethyl acetate is not filtered, and concentrated, and ethyl acetate is obtained, and the sticky filtrate is obtained, and ethyl acetate is filtered,
The compound I is:
The compound II is:
the compound II' is:
3. A process for preparing hexahydrofuro [2,3-b ] -furan-3-ol type VI includes such steps as adding methanol and sodium carbonate to intermediate type V compound, thermal insulating reaction at 25-30 deg.C, sampling for 8-10 hr, detecting, filtering, eluting with methanol, concentrating filtrate at 40-50 deg.C to obtain oily substance, adding water and toluene, stirring, laying aside, collecting water layer, cooling to-2-5 deg.C, adding concentrated hydrochloric acid at 0-5 deg.C, thermal insulating for 5-8 hr, sampling, GC detecting, regulating pH value to 7-8 with sodium carbonate, concentrating at 50-70 deg.C to obtain oily substance, stirring with ethyl acetate, filtering, concentrating filter cake with ethyl acetate, concentrating under reduced pressure until no liquid flows out,
The formula V is:
The formula V' is:
4. A process for preparing hexahydrofuro [2,3-b ] -furan-3-ol VI includes such steps as adding compound I, glycol methyl ether and p-toluenesulfonic acid in four-mouth dry flask, stirring at 20-25 deg.C, sampling, detecting, regulating pH value to 7-8 by sodium carbonate, concentrating at 50-70 deg.C, filtering, eluting with methanol, concentrating filtrate at 40-50 deg.C to obtain oily substance, stirring with water and toluene, collecting water layer, cooling to-2-5 deg.C, adding concentrated hydrochloric acid, sampling, GC, regulating pH value to 7-8 by sodium carbonate, concentrating to obtain oily substance, adding ethyl acetate, stirring, filtering, eluting with ethyl acetate, concentrating until no liquid is reacted,
The formula I is:
The formula V is:
The formula V' is:
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910706770.0A CN112300186B (en) | 2019-08-01 | 2019-08-01 | Process for preparing hexahydrofurofuranol derivative, intermediate and process for preparing the same |
PCT/CN2020/104791 WO2021018085A1 (en) | 2019-08-01 | 2020-07-27 | Preparation method for hexahydrofurofuranol derivative, and intermediate of the derivative and preparation method therefor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910706770.0A CN112300186B (en) | 2019-08-01 | 2019-08-01 | Process for preparing hexahydrofurofuranol derivative, intermediate and process for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112300186A CN112300186A (en) | 2021-02-02 |
CN112300186B true CN112300186B (en) | 2024-04-30 |
Family
ID=74230222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910706770.0A Active CN112300186B (en) | 2019-08-01 | 2019-08-01 | Process for preparing hexahydrofurofuranol derivative, intermediate and process for preparing the same |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112300186B (en) |
WO (1) | WO2021018085A1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1753898A (en) * | 2002-12-27 | 2006-03-29 | 住友化学株式会社 | Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof |
CN101541775A (en) * | 2006-11-09 | 2009-09-23 | 泰博特克药品有限公司 | Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
EP2634180A1 (en) * | 2012-03-01 | 2013-09-04 | Lonza Ltd. | Enzymatic process for the preparation of butyrolactones |
CN103864813A (en) * | 2012-12-18 | 2014-06-18 | 上海迪赛诺化学制药有限公司 | Synthetic methods of hexahydrofuro[2,3-b]furan-3-ol and enantiomer thereof |
CN103896886A (en) * | 2012-12-31 | 2014-07-02 | 上海迪赛诺化学制药有限公司 | Darunavir midbody as well as preparation method and application thereof |
CN104520262A (en) * | 2012-08-09 | 2015-04-15 | 住友化学株式会社 | Method for producing hexahydrofurofuranol derivative |
CN110272398A (en) * | 2018-03-16 | 2019-09-24 | 江苏瑞科医药科技有限公司 | The preparation method of hexahydro furyl and furans 01 derivatives, wherein mesosome and preparation method thereof |
-
2019
- 2019-08-01 CN CN201910706770.0A patent/CN112300186B/en active Active
-
2020
- 2020-07-27 WO PCT/CN2020/104791 patent/WO2021018085A1/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1753898A (en) * | 2002-12-27 | 2006-03-29 | 住友化学株式会社 | Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof |
CN101541775A (en) * | 2006-11-09 | 2009-09-23 | 泰博特克药品有限公司 | Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
EP2634180A1 (en) * | 2012-03-01 | 2013-09-04 | Lonza Ltd. | Enzymatic process for the preparation of butyrolactones |
CN104520262A (en) * | 2012-08-09 | 2015-04-15 | 住友化学株式会社 | Method for producing hexahydrofurofuranol derivative |
CN103864813A (en) * | 2012-12-18 | 2014-06-18 | 上海迪赛诺化学制药有限公司 | Synthetic methods of hexahydrofuro[2,3-b]furan-3-ol and enantiomer thereof |
CN103896886A (en) * | 2012-12-31 | 2014-07-02 | 上海迪赛诺化学制药有限公司 | Darunavir midbody as well as preparation method and application thereof |
CN110272398A (en) * | 2018-03-16 | 2019-09-24 | 江苏瑞科医药科技有限公司 | The preparation method of hexahydro furyl and furans 01 derivatives, wherein mesosome and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112300186A (en) | 2021-02-02 |
WO2021018085A1 (en) | 2021-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002096899A1 (en) | Synthesis of cannabinoids | |
CN110790763A (en) | Process for preparing pyridobipyrimidine and pyridobipyrazole derivatives | |
CN112300186B (en) | Process for preparing hexahydrofurofuranol derivative, intermediate and process for preparing the same | |
CN111620808B (en) | 2-aldehyde indole compound and preparation method thereof | |
CN112457339A (en) | Synthetic method of pyrrole [1,2-a ] quinoxaline derivative | |
CN110256411B (en) | Preparation method of 2, 3-disubstituted benzo-gamma-pyrone derivative | |
CN1204133C (en) | 3-(1-hydroxy-amylene)-5-nitro-3H-benzfuran-2-one, its prepn. method and use | |
CN113651827B (en) | Preparation of pyrano [2,3-b]Process for preparing indol-2-ones | |
CN111303096B (en) | Synthesis method of polysubstituted 1, 3-dihydronaphtho [2,3-c ] furan derivative | |
CN112939900B (en) | Preparation method of buvaracetam intermediate | |
CN109912640B (en) | Preparation method of 2-pyrrolidone compound | |
CN109851599B (en) | Preparation method of 2-aminobenzofuran compound | |
CN108467382B (en) | Preparation method of 4H-chromene derivative | |
US8742077B2 (en) | Method for preparing 1,6:2,3-dianhydro-β-D-mannopyranose | |
JP2008094744A (en) | Process for producing piperidin-4-one derivative using bisaminol ether compound | |
CN110483506B (en) | Novel method for constructing 2- (2-thienyl) imidazole [1,2-a ] pyridine-3-aldehyde by using DMF as formylation reagent | |
CN113200980B (en) | Method for synthesizing indolizine compound under catalysis of silver | |
CN110483504B (en) | Novel method for constructing 2- (2-naphthyl) imidazole [1,2-a ] pyridine-3-aldehyde by using DMF (dimethyl formamide) as formylation reagent | |
JP5574476B2 (en) | Method for producing carbonate ester | |
CN111574328B (en) | Economical and practical resolution method of 2,2' -biphenol compound | |
CN115286568B (en) | Preparation method of 2-hydroxy-4-trifluoromethyl pyridine | |
CN110627721A (en) | Phenanthridine compound and synthesis method thereof | |
CN116041298B (en) | Preparation method of polysubstituted naphtho [2,1-b ] furan compound | |
CN112824411B (en) | Bridged ring isoindolinone derivatives, and preparation method and application thereof | |
CN116283761B (en) | 3-Alkenyl ketone substituted quinoline-2-ketone and green synthesis method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |